Related Experiment Video
Updated: Feb 18, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Cardiogenic Shock
Semhar Z Tewelde1, Stanley S Liu2, Michael E Winters3
1Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA.
Insights
Cardiogenic shock (CS) occurs when the heart cannot pump enough blood, leading to organ damage and death. Prompt diagnosis and treatment, including mechanical support and reperfusion therapy, are crucial for patient survival.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a life-threatening condition characterized by inadequate cardiac pump function, leading to critical tissue hypoperfusion.
- Delayed recognition and treatment of CS can result in rapid organ dysfunction and mortality.
Purpose of the Study:
- To outline the essential diagnostic evaluations and therapeutic strategies for patients presenting with suspected cardiogenic shock.
- To emphasize the importance of timely intervention for improving outcomes in CS.
Main Methods:
- Diagnostic workup includes electrocardiogram, chest radiograph, laboratory studies, and bedside echocardiography.
- Initial management focuses on restoring cardiac output and tissue perfusion.
- Advanced therapies involve mechanical circulatory support and emergent reperfusion.
Main Results:
- Early identification and comprehensive evaluation are key to managing CS.
- Pharmacologic therapy is the first line of treatment, but mechanical support is vital for refractory cases.
- Emergent reperfusion strategies, such as percutaneous coronary intervention or coronary artery bypass grafting, are critical for long-term recovery.
Conclusions:
- Cardiogenic shock necessitates rapid diagnosis and multifaceted treatment approaches.
- A combination of supportive care, mechanical circulatory support, and timely reperfusion therapy is essential for improving survival rates in CS patients.
Abstract:
Cardiogenic shock (CS) is a physiologic state in which cardiac pump function is inadequate to perfuse the tissues. If CS is not rapidly recognized and treated, tissue hypoperfusion can quickly lead to organ dysfunction and patient death. Evaluation of patients with suspected CS should include an electrocardiogram, chest radiograph, laboratory studies, and bedside echocardiogram. Initial resuscitation is directed toward restoring cardiac output and tissue perfusion. Mechanical circulatory support is indicated for patients with CS who do not respond to pharmacologic therapy. Ultimately, these patients should undergo emergent reperfusion therapy with either percutaneous coronary intervention or coronary artery bypass grafting.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Introduction Cardiac Emergencies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation IV: Pharmacological Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy I: Introduction and Classification

